Boehringer Ingelheim

Boehringer snaps up Pharmaxis liver disease drug
Pharma Times
Mon, 05/18/15 - 09:06 am
Boehringer Ingelheim
Pharmaxis
NASH
PXS4728A
FDA warns on newer class of type 2 diabetes drugs
Yahoo/Reuters
Sat, 05/16/15 - 02:04 pm
FDA
diabetes
type 2 diabetes
AstraZeneca
Farxiga
Eli Lilly
Jardiance
Boehringer Ingelheim
JNJ
Invokana
SGLT2 inhibitor
Big Pharma's cardiovascular sales ain't what they used to be
Fierce Pharma
Thu, 05/7/15 - 11:22 am
Big Pharma
Boehringer Ingelheim
Novartis
Pfizer
AstraZeneca
Sanofi
It’s Been One of “Those Weeks” in Hatch-Waxman World: Another Two Lawsuits and Two Court Decisions
FDA Law Blog
Fri, 05/1/15 - 10:11 am
FDA
Hatch Waxman Act
Spectrum Pharmaceuticals
Boehringer Ingelheim
Otsuka
FDA gives Boehringer's Pradaxa antidote a boost with fast-track review
Fierce Pharma
Thu, 04/23/15 - 01:34 pm
FDA
Boehringer Ingelheim
fast track
Pradaxa
idarucizumab
Pharma's getting savvier about social, with Boehringer, Bayer leading the pack
Fierce Pharma Marketing
Wed, 04/22/15 - 09:48 am
social media
Bayer
Boehringer Ingelheim
Boehringer posts flat earnings on stagnant Pradaxa sales
Yahoo/Reuters
Wed, 04/22/15 - 09:02 am
Boehringer Ingelheim
earnings
J&J's Invokana fends off new SGLT2 rivals to hit $278M in Q1
Fierce Pharma Marketing
Wed, 04/15/15 - 09:28 am
JNJ
Invokana
SGLT2 inhibitor
diabetes
Boehringer Ingelheim
Eli Lilly
Jardiance
Glyxambi
The largest biopharma layoffs of 2014
Fierce Pharma
Tue, 04/7/15 - 11:10 am
layoffs
Amgen
Novartis
Allergan
GSK
Boehringer Ingelheim
Actavis
AstraZeneca
Psoriasis data wars heat up at AAD with Novartis, Boehringer studies
Fierce Pharma Marketing
Thu, 03/26/15 - 07:38 am
Novartis
psoriasis
Boehringer Ingelheim
Pfizer
Xeljanz
Cosentyx
JNJ
Stelara
BI-655066
Amgen
AstraZeneca
Merck
Eli Lilly
Pradaxa antidote goes to FDA
Medical Marketing and Media
Mon, 03/2/15 - 04:40 pm
Pradaxa
FDA
idaricizumab
Boehringer Ingelheim
Boehringer's sales slide triggers job-chopping in Connecticut
Fierce Biotech
Tue, 02/17/15 - 12:48 pm
Boehringer Ingelheim
layoffs
Connecticut
R&D
FDA approves Boehringer-Lilly drug for type-2 diabetes patients
Yahoo/Reuters
Mon, 02/2/15 - 11:01 am
FDA
Eli Lilly
Boehringer Ingelheim
diabetes
type 2 diabetes
Glyxambi
EC clears Boehringer Ingelheim's Ofev for idiopathic pulmonary fibrosis
First Word Pharma
Mon, 01/19/15 - 12:02 pm
Boehringer Ingelheim
Ofev
IPF
idiopathic pulmonary fibrosis
Europe
Sanofi, BI Enter Manufacturing Collaboration for Biologics
Drug Discovery and Development
Mon, 01/19/15 - 11:57 am
Sanofi
Boehringer Ingelheim
R&D
biologics
Boehringer Ingelheim Weighs Sale of U.S. Generics Business Roxane Labs
TheStreet.com
Thu, 01/15/15 - 12:07 pm
generics
M&A
Boehringer Ingelheim
Roxane Laboratories
Europe gives green light to AbbVie hepatitis C medicine, others
Yahoo/Reuters
Fri, 11/21/14 - 08:11 am
Europe
AbbVie
hepatitis C
dasabuvir
Sanofi
eliglustat
Novartis
secukinumab
Merck
Vorapaxar
Boehringer Ingelheim
nintedanib
Boehringer taps WellPoint's outcomes data to develop new a-fib drugs
Fierce Biotech
Fri, 11/14/14 - 11:03 am
Boehringer Ingelheim
Wellpoint
atrial fibrillation
R&D
clinical outcomes
Pradaxa antidote enters Phase III
Medical Marketing and Media
Tue, 11/11/14 - 10:44 am
Pradaxa
Boehringer Ingelheim
A tale of two studies: Prescribe Pradaxa 'with caution'? Or rely on FDA's safety backing?
Fierce Pharma Marketing
Thu, 11/6/14 - 08:58 am
Pradaxa
Boehringer Ingelheim
FDA

Pages